Showing 401-410 of 2442 results for "".
Advances in Neuromodulation for Essential Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/advances-in-neuromodulation-for-essential-tremor/32163/Advancements in neuromodulation continue to expand treatment options for medication-refractory essential tremor.Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://reachmd.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Managing Symptoms of Anxiety, Panic, Depression, Apathy, and Pseudobulbar Effect in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/managing-symptoms-of-anxiety-panic-depression-apathy-and-pseudobulbar-effect-in-individuals-with-parkinson-disease/37655/Neuropsychiatric symptoms associated with Parkinson disease, including anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment as well as consideration of various treatment options to improve quality of life in this population.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Etiology and Treatment of Urogenital Dysfunction in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/etiology-and-treatment-of-urogenital-dysfunction-in-individuals-with-parkinson-disease/37653/Urogenital dysfunction is a common nonmotor symptom observed in people with Parkinson disease which can negatively impact quality of life, necessitating careful investigation and prompt treatment.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31085/Managing Personality Disorders in Dementia Patients: Expert InsightsIn the December 2007 issue of *Practical Neurology*, a panel of experts discusses the complexities of treating personality disorders in dementia patients, focusing on pharmacological strategies and the implications of recent studies
Moyamoya: An Update for the Practicing Neurologist
https://practicalneurology.com/diseases-diagnoses/stroke/moyamoya-an-update-for-the-practicing-neurologist/30306/Distinguishing between definite MMD, probable MMD, and MMS may not have significant practical implications.Migraine: Essentials of Patient Evaluation and Acute Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0209_01-php/30944/Clinicians who are knowledgeable of acute treatments, able to combine treatment modalities, and skilled at understanding patients' needs can successfully individualize treatment.Movement Disorders Moment: Parkinson Disease in the COVID-19 Era
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-parkinson-disease-in-the-covid-19-era/31774/The pandemic has risks for people with Parkinson disease both from COVID-19 and effects of the lockdown and raises questions about future risk of parkinsonism.